Carmelo García‐Monzón

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation”.

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

Nature Communications(2020)10.1038/s41467-020-16991-2

N/A

0DataRank · unranked

146 citations

Karen A. Fortner, Paula Iruzubieta, Teresa C. Delgado, Emily Giddings, Youdinghuan Chen +21 more

Rhamnan Sulfate Reduces Atherosclerotic Plaque Formation and Vascular Inflammation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.10.479785

N/A

0DataRank · unranked

1 citations

Almudena Gómez‐Hernández, Fuming Zhang, Limary M. Cancel, Xu Feng, Lufeng Yan +12 more

Increased let‐7d‐5p in non‐alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis

Liver International(2023)10.1111/liv.15581

N/A

0DataRank · unranked

13 citations

Andrea R. López‐Pastor, Tamara González‐Illanes, Paula González‐López, Raquel Huertas‐Lárez, Esther Rey +8 more